We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

NeuroMetrix Inc (NURO) USD0.0001

Sell:$4.11 Buy:$4.64 Change: $0.03 (0.68%)
Market closed |  Prices as at close on 26 April 2024 | Switch to live prices |
Sell:$4.11
Buy:$4.64
Change: $0.03 (0.68%)
Market closed |  Prices as at close on 26 April 2024 | Switch to live prices |
Sell:$4.11
Buy:$4.64
Change: $0.03 (0.68%)
Market closed |  Prices as at close on 26 April 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

NeuroMetrix, Inc. is a commercial-stage healthcare company that develops and commercializes neurotechnology devices to address unmet needs in the chronic pain and diabetes markets. The Company's products are wearable or hand-held medical devices enabled by proprietary consumables and software solutions that include mobile apps, enterprise software and cloud-based systems. The Company has two commercial brands. Quell is a wearable neuromodulation platform. DPNCheck is a point-of-care screening test for peripheral neuropathy. It operates two product categories: Diagnostic technology and Therapeutic technology. Diagnostic technology product category is engaged in point-of-care peripheral neuropathy assessment. Therapeutic technology product category is engaged in wearable neuromodulation for chronic pain syndromes. Its patients control and personalize the technology via a mobile phone application, and their utilization and certain clinical metrics may be tracked in the Quell Health Cloud.

Contact details

Address:
1000 Winter Street
WALTHAM
02451
United States
Telephone:
+1 (781) 8909989
Website:
https://www.neurometrix.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
NURO
ISIN:
US6412558800
Market cap:
$8.60 million
Shares in issue:
1.99 million
Sector:
Health Care Equipment
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Shai Gozani
    Chairman of the Board, President, Chief Executive Officer, Secretary
  • Thomas Higgins
    Chief Financial Officer, Senior Vice President, Treasurer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.